Nantes University Hospital
Clinical trials sponsored by Nantes University Hospital, explained in plain language.
-
Poop pills may stop gut pouch Flare-Ups in ulcerative colitis patients
Disease control OngoingThis study tests whether a fecal microbiota transplant (FMT) from a healthy donor can delay or prevent recurrent pouchitis in people with ulcerative colitis who have had ileal pouch-anal anastomosis surgery. About 42 adults with chronic pouchitis will receive either FMT or a sham…
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Eczema patients may soon need fewer shots
Disease control OngoingThis study tests whether people with controlled atopic dermatitis (eczema) can safely take dupilumab less often without losing control of their disease. About 256 teens and adults who have been on the standard every-2-week dose for at least a year will either stay on that schedul…
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New clip procedure could offer High-Risk heart patients a safer alternative to surgery
Disease control OngoingThis study tests whether a minimally invasive clip repair (MitraClip) is as effective as open-heart surgery for people with severe mitral regurgitation who are at high risk for surgery. About 330 participants will be randomly assigned to one of the two treatments and followed for…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Can extra oxygen stop ankle surgery scars from getting infected?
Disease control OngoingThis study looks at whether giving extra oxygen through the nose can lower the chance of wound problems after ankle fracture surgery. It includes 200 patients who are at higher risk due to issues like diabetes, smoking, or complex fractures. Half will get oxygen therapy while in …
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Smart combo therapy aims to wipe out hidden myeloma cells
Disease control OngoingThis study tests whether adding T-cell redirecting drugs (teclistamab and talquetamab) to standard therapy can eliminate remaining cancer cells in people with newly diagnosed multiple myeloma. About 103 adults under 66 will receive one of two drug combinations based on their mini…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New scan could spare heart patients from invasive procedure
Diagnosis OngoingThis study tests whether a special heart scan (dynamic SPECT) can accurately detect leftover blockages in heart attack survivors, compared to the current standard invasive test (FFR). About 60 adults with multiple blocked arteries will get both tests. If the scan works well, it c…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
New imaging agent could sharpen multiple myeloma detection
Diagnosis OngoingThis study is testing whether a new radioactive tracer called PentixaFor can find multiple myeloma lesions more accurately than the standard FDG tracer during PET scans. Researchers will compare the two tracers in 45 patients who are either starting first-line treatment or have r…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Apr 30, 2026 15:49 UTC
-
Spirulina compound may shield cancer patients from chemo nerve pain
Symptom relief OngoingThis study tests whether a natural substance from spirulina (phycocyanin) can reduce nerve damage caused by oxaliplatin chemotherapy in people with advanced gastrointestinal cancers. About 110 participants will receive either phycocyanin or a placebo during their chemo. The goal …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Scientists hunt for hidden genes behind naturally low cholesterol
Knowledge-focused OngoingThis study aims to find new genes that cause very low cholesterol levels (a condition called FHBL). Researchers are recruiting 435 people with FHBL and their family members to collect DNA and urine samples. By analyzing the genetic makeup of these families, they hope to discover …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 01:01 UTC
-
Gene hunt for childhood heart defects begins
Knowledge-focused OngoingThis study aims to find new genes linked to two specific types of congenital heart defects (transposition of the great arteries and congenitally corrected transposition). Researchers will analyze DNA from 300 children with these conditions and their parents. The goal is to improv…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC
-
New study tracks hidden blood sugar marker in diabetes patients
Knowledge-focused OngoingThis study looks at how a measure called the Hemoglobin Glycation Index (HGI) changes over time in people with diabetes. Researchers will track 750 adults who already use continuous glucose monitors. The goal is to better understand this blood sugar marker, not to test a new trea…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
AI decodes social secrets behind brain aneurysm ruptures
Knowledge-focused OngoingThis study looks at how social factors like income, housing, and lifestyle affect the risk of a brain aneurysm bursting. Researchers will use artificial intelligence to analyze health records from 1,800 adults. The goal is to better predict who is at risk and improve prevention.
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC